Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- befree-2016 importedOn "2016-02-19" NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_assertion wasGeneratedBy ECO_0000203 NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_assertion wasDerivedFrom befree-2016 NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_assertion SIO_000772 21070851 NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_assertion evidence source_evidence_literature NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.
- NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_assertion description "[We have investigated the role of the main endocannabinoid anandamide-metabolizing enzyme (fatty acid amide hydrolase; FAAH) in myocardial injury induced by an important chemotherapeutic drug, doxorubicin (DOX; known for its cardiotoxicity mediated by increased reactive oxygen and nitrogen species generation), using well-established acute and chronic cardiomyopathy models in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851959.RA5Ugf_yxM-72CcsnVYh7q2MBS78oXj33QMv4G-nHPWA0130_provenance.